Ultima-Epithalon at a Glance
Ultima-Epithalon 50mg is a synthetic tetrapeptide sequence (Ala-Glu-Asp-Gly) developed for advanced laboratory research into telomerase enzyme modulation and cellular senescence pathways. This compound represents the bioactive sequence derived from the pineal gland peptide epitalon, manufactured to pharmaceutical standards by Ultima Peptides for research applications. Scientists at Stroid UK Shop investigate epithalon’s mechanisms in cellular biology studies, particularly its interaction with telomerase reverse transcriptase (TERT) expression in experimental models. The tetrapeptide structure enables researchers to examine how short peptide sequences influence chromosomal stability and cellular division processes in controlled laboratory environments.
Laboratory Applications
Research teams examine Ultima-Epithalon in studies investigating telomere length maintenance, circadian rhythm regulation, and age-related cellular changes in various model systems. The compound’s tetrapeptide structure allows for investigation of peptide-mediated gene expression changes, particularly those affecting DNA repair mechanisms and oxidative stress responses. Scientists studying epitalon peptide research evaluate its effects on melatonin production pathways and pineal gland function in experimental protocols. Epithalon research extends to examination of its influence on immune system modulation and inflammatory response pathways in cellular and tissue culture models.
Research Specifications
| Peptide Sequence | Ala-Glu-Asp-Gly |
|---|---|
| Molecular Weight | 390.35 g/mol |
| CAS Registry | 307297-39-8 |
| Purity Grade | Research grade (verify with supplier) |
| Appearance | White lyophilised powder |
| Storage Requirements | -20°C, protect from light and moisture |
| Reconstitution | Bacteriostatic water or saline for research use |
| Stability | 2-8°C when reconstituted, use within research timeframe |
Research protocols examine epithalon’s interaction with various cellular targets including telomerase enzyme complexes, circadian clock proteins, and antioxidant enzyme systems. Scientists investigating selective research compounds often compare peptide-mediated effects with other molecular modulators in comprehensive experimental designs. The compound’s stability profile enables extended research studies examining long-term cellular responses to peptide exposure. Investigators studying peptide research applications analyse epithalon’s bioactivity across different experimental conditions and model systems.
Research Compliance
Ultima-Epithalon 50mg is manufactured exclusively for in-vitro research applications and laboratory studies. This product is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must maintain appropriate laboratory protocols and safety procedures when handling this research compound.
